Nofetumomab merpentan: Difference between revisions
Jump to navigation
Jump to search
m Protected "Nofetumomab merpentan": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
| Line 32: | Line 32: | ||
{{mousemonoclonals}} | {{mousemonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
Latest revision as of 14:21, 20 August 2012
Overview
Nofetumomab merpentan is a mouse monoclonal antibody and which it it used to treat cancer. Nofetumomab has it's chelator, merpentan. It also has a radioisotope, technetium-99m Tc.